Publications by authors named "Meixiu Gu"

Claim this Profile
D
Distinct pathogenic mechanisms underlying two protein C variants (p.Arg211Gln and p.Val367Met) in a thrombophilic family: integrated functional and structural analyses.
Huayang Zhang, Chong Wang, Huiqin Jiang, Ying Zhao, Li Zhang, Meixiu Gu, Wei Guo

Hum Genomics· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of peripheral blood lymphocyte subsets and cytokine profiles in patients with respiratory syncytial virus infection.
Minle Wu, Xiaolian Wang, Jie Zhu, Chong Wang, Meixiu Gu, Wei Guo

Microbes Infect· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STRN3 promotes tumour growth in hepatocellular carcinoma by inhibiting the hippo pathway.
Jie Zhu, Wenjia Tang, Peiqi Fang, Chong Wang, Meixiu Gu, Wei Guo

J Cell Mol Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical application of a fully automated blood collection robot and its assessment of blood collection quality of anticoagulant specimens.
Chong Wang, Meixiu Gu, Jie Zhu, Shuo Yang, Wenjia Tang, Wei Guo

Front Med (Lausanne)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Basiliximab on Clinical Treg Detection through the Interference with CD25 Binding Site.
Jie Zhu, Yu Gong, Hui Wu, Peiqi Fang, Meixiu Gu, Wei Guo

Ann Clin Lab Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining γ-GT, PIVKA-II, and AFP to predict long-term prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lin Sun, Meixiu Gu, Jiabin Cai, Wenjing Yang, Baishen Pan, Wei Guo

Clin Exp Pharmacol Physiol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunomodulatory activity of lenvatinib prompts the survival of patients with advanced hepatocellular carcinoma.
Jie Zhu, Peiqi Fang, Chong Wang, Meixiu Gu, Baishen Pan, Wei Guo

Cancer Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mean Corpuscular Volume Predicts In-Stent Restenosis Risk for Stable Coronary Artery Disease Patients Receiving Elective Percutaneous Coronary Intervention.
Lin Sun, Chunyan Zhang, Yinghui Ju, Bin Tang, Meixiu Gu, Wei Guo

Med Sci Monit· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis